Optiver Holding
KYTX icon

Optiver Holding’s Kyverna Therapeutics KYTX Stock Holding History

Optiver Holding’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26K Buy
+142
New +$1.26K ﹤0.01% 2433

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Optiver Holding's KYTX Position: Q2 2026 in Review

Optiver Holding opened a new position in Kyverna Therapeutics (KYTX) in Q2 2026: 142 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #2433 among its holdings.

121 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Optiver Holding held 142 shares of Kyverna Therapeutics worth $1.26K as of Q2 2026.
  • Kyverna Therapeutics was a new Optiver Holding position in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2433 holding.
  • 121 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.